Literature DB >> 17568024

Do cancer cells express functional erythropoietin receptors?

Gregory D Longmore1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17568024     DOI： 10.1056/NEJMp078112

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  7 in total

1.  Macrophages as novel target cells for erythropoietin.

Authors:  Lilach Lifshitz; Galit Tabak; Max Gassmann; Moshe Mittelman; Drorit Neumann
Journal:  Haematologica       Date:  2010-06-30       Impact factor: 9.941

Review 2.  Anemia in the preoperative patient.

Authors:  Manish S Patel; Jeffrey L Carson
Journal:  Med Clin North Am       Date:  2009-09       Impact factor: 5.456

3.  The Role of Supportive Therapy in the Era of Modern Adjuvant Treatment - Current and Future Tools.

Authors:  Rupert Bartsch; Guenther G Steger
Journal:  Breast Care (Basel)       Date:  2009-06-23       Impact factor: 2.860

4.  Quantitative comparison of erythropoietin receptor levels in the epithelial versus endothelial fractions of primary breast tumors.

Authors:  Chris P Miller; Nicole Urban; C Anthony Blau
Journal:  Anticancer Res       Date:  2011-04       Impact factor: 2.480

5.  EPO receptor gain-of-function causes hereditary polycythemia, alters CD34 cell differentiation and increases circulating endothelial precursors.

Authors:  Silverio Perrotta; Valeria Cucciolla; Marcella Ferraro; Luisa Ronzoni; Annunziata Tramontano; Francesca Rossi; Anna Chiara Scudieri; Adriana Borriello; Domenico Roberti; Bruno Nobili; Maria Domenica Cappellini; Adriana Oliva; Giovanni Amendola; Anna Rita Migliaccio; Patrizia Mancuso; Ines Martin-Padura; Francesco Bertolini; Donghoon Yoon; Josef T Prchal; Fulvio Della Ragione
Journal:  PLoS One       Date:  2010-08-05       Impact factor: 3.240

Review 6.  Treatment strategies in elderly patients with multiple myeloma: current status.

Authors:  Hang Quach; H Miles Prince; Linda Mileshkin
Journal:  Drugs Aging       Date:  2007       Impact factor: 3.923

7.  Erythropoiesis-stimulating agents: benefits and risks in supportive care of cancer.

Authors:  B L Melosky
Journal:  Curr Oncol       Date:  2008-01       Impact factor: 3.677
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.